NPI-0052 is a natural proteasome inhibitor shown by us and others to induce RKIP via NF-κB/Snail inhibition, resulting in reversal of prostate cancer cell EMT, migration, invasion, and chemo/immune sensitization [26,130]. Here, NFKB1 is linked to prostate cancer.